Moovcare

What Moovcare does

Moovcare is a regulated digital medical device for oncology telemonitoring, developed and operated by Israel-based Sivan Innovation and distributed in Europe through its French subsidiary Sivan France. The platform captures patient-reported outcomes via a weekly web questionnaire completed on smartphone, tablet, or computer; responses are processed by an in-house algorithm and reviewed by a dedicated team of oncologists and specialized oncology nurses. When clinical signals warrant, the team contacts the patient and notifies the treating oncologist to expedite intervention, while explicitly not interfering with the oncologist's therapeutic decisions. The product portfolio comprises Moovcare® Poumon, a Class IIa CE-marked web application for personalized telemonitoring of lung cancer patients (also Class I in Canada), and Moovcare® Toxicité, an early-detection module for anti-cancer treatment toxicities, complemented by a supportive care module addressing anxiety, quality of life, and caregiver reassurance.

The business operates a recurring-revenue subscription model under which healthcare providers, primarily oncology teams and cancer centers such as Institut Curie, enroll patients into structured weekly monitoring. Distribution combines direct enterprise enrollment via the medical-professional portal, direct patient self-registration through a patient portal, and a regulated distribution channel in which Sivan France acts as importer and KAPSIKUM serves as EU Authorized Representative. Clinical validation includes studies on over 3,000 patients published in JAMA, JNCI, the Journal of Thoracic Oncology, and ASCO proceedings, with an Institut Curie clinical study reporting 94% patient ease-of-use.

Commercially the company remains privately held by Sivan Innovation, with no disclosed external venture or growth-equity funding and a headcount of 11-50 employees. Geographic reach is concentrated in the EU (with France as the primary market), Canada, and Israel, and pricing is quote-based and not publicly disclosed, consistent with a regulated medical device reimbursed through institutional payers rather than direct-to-consumer channels.

Name

Moovcare

Legal name

Sivan Innovation

Website

https://moovcare-patient.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Moovcare is a CE-marked Class IIa digital medical device by Sivan Innovation that provides weekly, algorithm-assisted telemonitoring for adult cancer patients, with a focus on lung cancer and treatment toxicity, supervised by oncology specialists across France, Israel, and Canada.

Ownership category

akta.pro rank

Product category

Oncology Telemonitoring Software

NAICS

Offices of Physicians (62111), Home Health Care Services (62161)

SIC

Services-Health Services (8000), Services-Home Health Care Services (8082)

akta.pro primary industry

Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

akta.pro secondary industry

Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Oncology telemonitoring
• Cancer patient monitoring
• Remote symptom tracking
• Medical device software
• Patient-reported outcomes

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Medical Device Subscription/Telesurveillance Services: Moovcare operates as a Class IIa medical device providing telemonitoring services to cancer patients. The subscription model involves weekly patient monitoring with medical supervision, likely billed through healthcare systems or directly to patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Moovcare is a CE-marked Class IIa medical device web-application (developed by Israeli parent Sivan Innovation, distributed via French subsidiary Sivan France) that delivers weekly telemonitoring for adult cancer patients, with flagship variants for lung cancer (Moovcare® Poumon) and treatment-toxicity detection (Moovcare® Toxicité). Each week, patients complete a structured symptom questionnaire via smartphone, tablet, or computer; responses are analyzed by an algorithm and reviewed by a dedicated team of oncologists and specialized oncology nurses who contact the patient and inform the treating oncologist when a clinical signal requires attention. The offering also includes a supportive care module that provides personalized advice for improving comfort and quality of life between consultations.

Product overview

Moovcare is a unified medical device platform for cancer patient telemonitoring, developed by Sivan Innovation. The platform is anchored by a core weekly questionnaire system that collects patient-reported outcomes and analyzes them via an algorithm supervised by oncology specialists. The portfolio includes two specialized products: Moovcare® Poumon for lung cancer patients and Moovcare® Toxicité for toxicity detection. The system operates as a relay between consultations, detecting relapses and complications earlier while also supporting supportive care (Soins de Support) through personalized recommendations.

Differentiator

Problem solved

Functional benefit

Brands

• Moovcare® Poumon: Web-application de télésurveillance des patients atteints d'un cancer du poumon.
• Moovcare® Toxicité

Products and services

• Moovcare® Poumon A Class IIa CE-marked medical device web-application for personalized weekly telemonitoring of patients diagnosed with lung cancer, designed to detect relapses and complications early through structured symptom questionnaires analyzed by an algorithm and supervised by oncologists and specialized oncology nurses. Targeted at adult lung cancer patients enrolled through their oncology team.
• Moovcare® Toxicité A web-application for early detection of toxicities related to anti-cancer treatments, enabling patients to report symptoms that are algorithmically analyzed and clinically reviewed to identify treatment-related adverse events between consultations. Intended for oncology patients undergoing anti-cancer therapy who are at risk of treatment-related toxicities.

Quantifiable outcome

• 94% of patients find the application easy to use
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Institut CuriecoreStrategic or Co-development PartnerMajor French cancer research and treatment center that conducted clinical studies validating Moovcare's efficacy, demonstrating 94% patient ease-of-use ratings. Institut Curie represents a key clinical validation partner for the platform.
• KAPSIKUMcoreImplementation/ SI/ Consulting PartnerEU Authorized Representative based in Saclay, France. KAPSIKUM handles regulatory compliance representation for Moovcare's CE-marked medical devices in the European Union market.
• Sivan FrancecoreStrategic or Co-development PartnerFrench subsidiary of Sivan Innovation headquartered in Asnières-sur-Seine. Functions as the importer and distributor for Moovcare products in the European market.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Noona Healthcare: Noona is an oncology patient engagement and symptom tracking platform acquired by Elekta, directly competing with Moovcare in the cancer telemonitoring space with broader oncology coverage.
• Carevive Systems: Carevive provides cancer care management and remote patient monitoring software for oncology practices, with similar patient-reported outcomes capture and symptom tracking capabilities as Moovcare.
• Kaiku Health: Kaiku Health (acquired by Elekta) provides a digital platform for cancer patient symptom monitoring with electronic patient-reported outcomes, very similar in product offering and oncology specialization to Moovcare.
• Equicare Health: Equicare Health provides oncology care coordination and patient engagement software for cancer centers, directly comparable to Moovcare in serving oncology practices with patient monitoring capabilities.

Emerging players

• Huma: Huma (formerly Medopad) is a digital health platform offering remote patient monitoring across multiple conditions including oncology, representing a more digitally-native and broader competitor to Moovcare.
• Current Health: Current Health (acquired by Best Buy) provides an RPM platform with wearable monitoring; while not oncology-specific, it intersects with Moovcare in the broader remote patient monitoring category.

Broad incumbents

• Elekta: Elekta acquired Kaiku Health and Noona, making it a major oncology software incumbent offering cancer patient monitoring as part of a broader radiation oncology and software portfolio.
• Biofourmis: Biofourmis is a broader AI-powered RPM platform with multi-condition coverage; while not oncology-specific, it competes for the same RPM budget within hospital systems and oncology departments.
• Vivify Health: Vivify Health is an established RPM platform serving chronic disease populations; it overlaps with Moovcare in remote patient monitoring infrastructure and competes for similar hospital system contracts.
• Varian Medical Systems: Varian (a Siemens Healthineers company) provides broad oncology software and now Noona for symptom monitoring, making it a much larger incumbent competing in the same oncology RPM space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/SivanInnovation
• YouTubeyoutube.com/channel/UC4fOM7l4Rg3LfCdUEr-2iHA
• LinkedInlinkedin.com/company/sivan-innovation

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Moovcare